Evidence guide
What tranexamic acid does in plastic surgery, how well it reduces bleeding, and how safe it is.
Written by Orr Shauly, MD, plastic surgery resident. Updated .
For information and education only, not medical advice.
The short answer.
Tranexamic acid (TXA) is a medicine that helps blood clots hold together by slowing their breakdown. In plastic surgery it is given through a vein, applied to the surgical area or mixed into local anesthetic to reduce bleeding and bruising. Across 30 randomized trials and 2,150 plastic surgery patients, intravenous TXA reduced blood loss and the need for transfusion, with no TXA-related complications.1 In breast surgery it has been associated with fewer hematomas, and a review of 216 trials found no increase in blood clots.2,3
- 30 Trials
- 2,150 patients
- Randomized trials of intravenous TXA in plastic surgery in a 2023 meta-analysis.1
- 7.3%
- hematoma with TXA in breast surgery
- Hematoma rate with TXA vs 12.9% without, across 5 studies and 1,139 breast surgery patients.2
- 10.0% - 3.8%
- hematoma after breast reduction
- Hematoma rate without TXA vs with intravenous TXA in a single-institution study of 464 breast reduction patients.4
- 2.1%
- blood clots with TXA
- Thromboembolic events with intravenous TXA vs 2.0% without, across 216 trials and 125,550 patients in all specialties.3
What tranexamic acid is.
When a blood vessel is injured, the body forms a clot made of a protein mesh called fibrin. Another system, called fibrinolysis, gradually breaks that clot down. Tranexamic acid blocks this breakdown, so clots that have already formed stay stable for longer.5 It does not create new clots by itself.
TXA has long been used in trauma, heart, orthopedic and obstetric surgery. Its use in plastic surgery has grown quickly, from facial procedures to breast and body contouring.6
How it is given.
- Intravenous: A dose is given through a vein during surgery.1
- Topical: TXA solution is applied directly to the surgical area before closing.7
- Local Infiltration: TXA is mixed with the local anesthetic or tumescent fluid injected into the tissues.8
Studies vary in dose, timing and route, and no single protocol has been established as best.6,8
The evidence at a glance.
| Study | Procedures | Patients | Main Finding |
|---|---|---|---|
| Wang 2023 (Intravenous)1 | Plastic Surgery | 2,150 | Less blood loss, transfusion risk about one third, no TXA complications |
| Wang 2023 (Local)7 | Plastic Surgery | 11 trials | Less blood loss and bruising, better surgical field |
| Laikhter 20229 | Aesthetic Surgery | 820 | 26.3 mL less blood loss, trend toward fewer hematomas |
| Liechti 20232 | Breast Surgery | 1,139 | Hematoma 7.3% vs 12.9%, seroma 11.5% vs 19.9% |
| Fijany 202510 | Breast, Body Contouring | 13 studies | Lower odds of hematoma, fewer infections with topical TXA |
| Al-Hashimi 202311 | Facelift | 150 | Less drainage and bruising, limited evidence |
Results by procedure.
- Rhinoplasty: There is high-certainty evidence that intravenous TXA reduces blood loss in rhinoplasty and other cosmetic procedures.6
- Facelift: In a single-surgeon study of 175 facelifts, topical or injected TXA roughly halved drain output and reduced bruising, with similar hematoma rates.12
- Breast Reduction: In 464 breast reduction patients, hematoma occurred in 10.0% without TXA, 3.8% with intravenous TXA and 2.5% with TXA plus a plant-based hemostatic powder.4
- Body Contouring: Across breast and body contouring studies, TXA was associated with lower odds of hematoma, while seroma and wound healing were not clearly different.10
Safety and blood clot risk.
The main theoretical concern with TXA is blood clots. In a meta-analysis of 216 randomized trials and 125,550 patients across all specialties, thromboembolic events occurred in 2.1% of patients given intravenous TXA vs 2.0% of controls, with no association between TXA and clot risk at any dose.3 In breast surgery studies, no thromboembolic events occurred in either group.2
TXA is generally avoided or used with caution in people with a history of blood clots, certain clotting disorders, recent stroke or seizures, or kidney problems, and the decision is made individually by the surgical team.
What we don't know yet.
- Best Route: Whether intravenous, topical or combined TXA works best for each procedure is unclear.6,8
- Hematoma: More high-quality trials are needed to confirm the effect on hematoma in facelift and breast surgery.6
- Swelling: Objective, standardized measures of bruising and swelling are still lacking.6
Common questions.
What is TXA used for in plastic surgery?
TXA is used to reduce bleeding during and after surgery. Studies also show less bruising and drainage after procedures such as rhinoplasty, facelift and breast surgery.
Does TXA cause blood clots?
Large analyses of randomized trials have not found an increased risk of blood clots with intravenous TXA. It is still used with caution in people who have had blood clots before.
Does TXA reduce bruising and swelling?
Most studies report less bruising, especially after facial procedures. Swelling has been harder to measure, and the evidence is less clear.
Is TXA given as a pill before surgery?
In plastic surgery studies, TXA is usually given through a vein during surgery, applied to the surgical area or mixed into the local anesthetic. The plan is decided by the surgical team.
Does TXA prevent hematoma?
TXA has been associated with fewer hematomas in breast surgery and body contouring. For facelift, the evidence is still limited, and careful surgical technique and blood pressure control remain essential.
Is TXA right for my surgery?
Only your surgical team can answer that. This guide is educational and cannot assess an individual case. A qualified plastic surgeon and anesthesiologist can review your medical history and decide with you.
Key terms.
- Tranexamic Acid (TXA)
- A medicine that slows the breakdown of blood clots and reduces bleeding.
- Antifibrinolytic
- A medicine that blocks fibrinolysis, the natural breakdown of blood clots.
- Hematoma
- A collection of blood under the skin or in a surgical space that may need to be drained.
- Seroma
- A collection of clear fluid in a surgical space.
- Thromboembolism
- A blood clot that forms in a vessel and may travel, such as a clot in the leg or lungs.
- Ecchymosis
- Bruising caused by blood leaking into the skin.
Research by Dr. Shauly on this topic.
References.
- 1.Wang S, Yang J, Lin L. Intravenous Application of Tranexamic Acid in Patients Undergoing Plastic Surgery: A Systematic Review and Meta-analysis with GRADE Quality Assessment. Aesthetic Plast Surg. 2024;48(3):543-58. PubMed
- 2.Liechti R, van de Wall BJM, Hug U, Fritsche E, Franchi A. Tranexamic Acid Use in Breast Surgery: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2023;151(5):949-57. PubMed
- 3.Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P, et al. Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Surg. 2021;156(6):e210884. PubMed
- 4.Om A, Kong BH, Shauly O, Cuzzone D, Garcia Nores G, Losken A. Use of Plant-Based Absorbable Hemostatic Powder and Intravenous Tranexamic Acid in Breast Reduction Patients Reduces Hematoma Rates. Ann Plast Surg. 2026;96(6S):S455-S458. PubMed
- 5.Soltany A, Alhallak N, Al Aissami M. Tranexamic acid in rhytidectomy: a scoping review. Ann Med Surg (Lond). 2023;85(10):4964-8. PubMed
- 6.Brown S, Brown T, Rohrich RJ. Clinical Applications of Tranexamic Acid in Plastic and Reconstructive Surgery. Plast Reconstr Surg. 2024;154(6):1253e-1263e. PubMed
- 7.Wang S, Yang J, Lin L. Local Application of Tranexamic Acid in Plastic Surgery Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Aesthetic Plast Surg. 2023;47(4):1633-43. PubMed
- 8.Keshavarz H, Lin WWC, Dodd S, Kung JY, Wong JN. Effectiveness and Safety of Topically Applied Tranexamic Acid with Epinephrine in Surgical Procedures: A Systematic Review. Eur Burn J. 2025;6(3):52. PubMed
- 9.Laikhter E, Comer CD, Shiah E, Manstein SM, Bain PA, Lin SJ. A Systematic Review and Meta-Analysis Evaluating the Impact of Tranexamic Acid Administration in Aesthetic Plastic Surgery. Aesthet Surg J. 2022;42(5):548-58. PubMed
- 10.Fijany AJ, Holan CA, Troia T, Montorfano L, Mubang RN, Givechian KB, et al. Tranexamic Acid in Body Contouring Surgery: A Systematic Review and Meta-Analysis. Aesthet Surg J. 2025;45(10):1026-34. PubMed
- 11.Al-Hashimi M, Kaur P, Charles W, Bhasta M, Nahai F, Khajuria A. A Systematic Review of the Efficacy and Safety of Tranexamic Acid in Facelift Surgery. Aesthet Surg J. 2023;43(11):1211-8. PubMed
- 12.Pou JD, Matabele MN, Robertson KM. Subcutaneous and Topical Tranexamic Acid Use During Rhytidectomy. Laryngoscope. 2025;135(5):1685-90. PubMed